Heart Disease

What Causes High Blood Pressure?

Blood pressure is the term used to describe the pressure exerted on the arterial walls as blood flows through them. This pressure is at its highest when the heart contracts and pumps blood through the arteries and is called the systolic pressure.

Coronary Artery Disease Characteristics

Heart Rate Abnormalities

Coronary Artery Disease Risk Factors

Heart Failure Diagnosis

Obesity and Metabolic Syndrome

Cardiogenic Shock Symptoms

What is Cardiogenic Shock?

Cardiogenic Shock Diagnosis

Cardiovascular Benefits of Blueberries

Heart attack and cardiac arrest difference

Hypertension Symptoms and Effects

See more featured articles »

Foods that Reduce Heartburn (Acid Reflux)

Cardiothoracic Imaging Techniques

LDL Cholesterol and Heart Disease

What is Coronary Artery Disease?

Cardiogenic Shock Treatment

Causes of Heartburn (Acid Reflux)

What is Carotid Artery Stenosis?

Heart Disease Biomarkers and Screening Tests

Drug-Eluting Stent Design

History of Chronic Obstructive Pulmonary Disease

Photoplethysmography (PPG) for Heart Disease

Heart Failure Pathophysiology

Coronary Artery Disease and Aspirin

High Blood Pressure Hypertension

Structure and Function of the Heart

Dieting for Obese Children

Coronary Artery Disease Prevention

Hypertrophic Cardiomyopathy Symptoms and Causes

Lowering Risk for Cardiovascular Disease

Heart Failure Causes

Drug-Eluting Stent Alternatives

Heart Attack Questions

Cardiovascular Disease Research

Heart Failure Prognosis

Heart Failure Terminology

Chronic Obstructive Pulmonary Disease Diagnosis

What is Heartburn (Acid Reflux)?

Causes and Symptoms of Hypoplastic Left Heart Syndrome

What is a Heart Attack?

Coronary Artery Disease Preventive Diets

How the Heart Pumps Blood

What is Cholesterol?

Heart Attack Diagnosis

What Causes A Heart Attack?

Why is Visceral Fat Dangerous?

Cholesterol Physiology

Diagnosis of Hypoplastic Left Heart Syndrome

Hypertrophic Cardiomyopathy Screening

Chronic Obstructive Pulmonary Disease Causes

Anti-Hypertensive Drugs

Heart Failure Management

Hidden Signs of Heart Problems

Heart Attack Symptoms

Cardiac Pharmaceutical Agents

Heart Attack Treatment

Chronic Obstructive Pulmonary Disease Treatment

Hypertension Diagnosis

High Blood Pressure in Children

Heart Failure Classification

Obesity in Adults

Hypertrophic Cardiomyopathy (HCM)

Hypercholesterolemia and Hypocholesterolemia

Heartburn (Acid Reflux) Prevention

Coronary Artery Disease Treatment

Cardiothoracic Surgery

Drug-Eluting Stent Indications

Abdominal Obesity and the Metabolic Syndrome

Carotid Artery Stenosis Treatment

What is Obesity?

Coronary Artery Disease and Omega-3 Fatty Acids

Diagnostic Tests for Hypertrophic Cardiomyopathy

Heart Failure

What is Cardiology?

Treatment of Hypoplastic Left Heart Syndrome

How is Acid Reflux Diagnosed?

Heartburn (Acid Reflux) Treatments

COPD and Sleep Apnea

Cardiovascular Drugs

Hypertrophic Cardiomyopathy Treatments

Obesity and Blood Pressure

Hypertension Risk Factors

Cardiovascular Disease Diagnosis

Chronic Obstructive Pulmonary Disease Symptoms

What is Heart Rate?

Pulmonary Rehabilitation for COPD

Hypoplastic Left Heart Syndrome (HLHS)

Coronary Artery Disease Pathophysiology

Heart Rate Reserve

Heartburn (Acid Reflux) Triggers

Surviving Heart Attack

Chronic Obstructive Pulmonary Disease Management

Myocardial T1 and T2 Mapping

Heart Failure Symptoms

What is Chronic Obstructive Pulmonary Disease?

Chronic Obstructive Pulmonary Disease Process

Hypertension Treatment

Link between Bisphenol A and Increase in Blood Pressure

High Cholesterol and Stroke Risk

Cardiology Procedures

Coronary Artery Disease Angina

What are Drug-Eluting Stents?

Prognosis for Hypoplastic Left Heart Syndrome

Target Heart Rate

What is high cholesterol?

Drug-Eluting Stent Risks

Carotid Artery Stenosis Diagnosis

Percutaneous Closure Procedure

Artificial Intelligence in Cardiology

What is Cardiovascular Disease?

Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)

Latest Heart Disease News and Research

App launched to track heart health after high-risk pregnancies

The MumCare app addresses postpartum cardiovascular risk, supporting women in managing health after pregnancy complications through personalized digital tools.

6 May 2026

Popular GLP-1 drugs significantly reduce major cardiovascular events,

Researchers evaluate the long-term cardiovascular safety and efficacy of GLP-1RAs in high-risk populations.

6 May 2026

Exercise remains essential alongside GLP-1 obesity treatments

As GLP-1 receptor agonists reshape obesity treatment, a new medical perspective published in the Journal of the American Medical Association, or JAMA, underscores a persistent gap in care: integrating exercise into weight management in ways patients can sustain.

5 May 2026

New method matures lab-grown heart cells for better research

Researchers at the University of Toronto's Institute of Biomedical Engineering have developed a new method to mature lab-grown heart cells, so they more closely resemble adult human heart tissue.

5 May 2026

Both low and high heart rates linked to stroke risk

A new study presented today at the European Stroke Organisation Conference (ESOC) 2026 suggests that both very low and very high resting heart rates are linked with an increased risk of stroke.

5 May 2026

U.S. bariatric surgery rates drop significantly amid GLP-1 surge

The number of metabolic and bariatric surgery procedures in the United States dropped below 200,000 in 2024 for the first time since 2020, a more than 20% decline from the prior year, according to new research presented today at the annual scientific meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

Bariatric surgery improves outcomes for patients with obesity and chronic kidney disease

Metabolic and bariatric surgery, also known as weight-loss surgery, dramatically improves outcomes for patients with obesity and chronic kidney disease (CKD), significantly reducing the risk of kidney failure, major cardiovascular events and death, according to new research presented here today at the annual meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

GLP-1 use surges as surgery rates drop for severe obesity

Drawing on electronic health records from nearly 20 million patients with severe obesity, researchers from University of California San Diego find that GLP-1 prescriptions have grown exponentially -- from less than 4,600 prescriptions in 2018 to more than 1.4 million in 2025 -- according to a new real-world analysis presented today at the annual scientific meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

Bariatric surgery costs significantly less than GLP-1 drugs over two years

A new real-world analysis of more than 90,000 patients with obesity and type 2 diabetes finds metabolic and bariatric surgery is costs significantly less than weekly injections of GLP-1 drugs over a two-year period, according to a new research presented today at the annual scientific meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

KIF13B protects heart function during sepsis by regulating lipid metabolism

Sepsis, a life-threatening condition caused by dysregulated host response to infection, remains a major cause of global mortality.

5 May 2026

Study reveals epigenetic adaptation of beta cells across lifespan and disease

As people age, most maintain normal blood sugar even as insulin resistance tends to rise. New research suggests that pancreatic beta cells help meet this demand through gradual epigenetic changes in regulatory regions of the genome that support beta-cell identity and function.

5 May 2026

GLP-1 drugs combined with surgery yield superior weight loss results

People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and bariatric surgery achieve substantially greater weight loss than with the medications alone, according to new research presented today at the annual meeting of the American Society for Metabolic and Bariatric Surgery.

5 May 2026

AI-driven model predicts type 1 diabetes risk with greater accuracy

Researchers use machine learning and genetic analysis to uncover type 1 diabetes risk factors, improving prediction accuracy and identifying patient subtypes.

5 May 2026

A new tool that predicts obesity-related disease risk beyond BMI

OBSCORE is a data-driven tool that identifies high-risk individuals for obesity-related diseases, enhancing treatment targeting beyond traditional BMI metrics.

5 May 2026

Blood tests years before pregnancy predict risk of hypertension

Pre-pregnancy blood biomarkers linked to hypertension risk highlight the potential for early intervention in managing hypertensive disorders of pregnancy.

5 May 2026

New research identifies stress response as trigger for heart inflammation

After a heart attack, the body rapidly floods the injured heart with neutrophils - white blood cells that help repair damage but can also make it worse when too many arrive too quickly.

4 May 2026

Learn B.E. F.A.S.T. to recognize stroke signs and save lives

A stroke can change a life in an instant. In the minutes after symptoms begin, quick action can help protect the brain, reduce long-term disability and save a life, according to the American Stroke Association, a division of the American Heart Association.

4 May 2026

A more accurate tool for assessing Arsenic toxicity

Public health experts estimate that more than 200 million people worldwide are exposed to arsenic through contaminated drinking water. Scientists know long-term exposure to arsenic is associated with increased risk of chronic illnesses like cancer and cardiovascular disease, but there hasn't been a reliable way to track these exposures and fully understand their effects on the body and the mechanisms behind them.

4 May 2026

Finding new ways to mimic ketamine’s antidepressant effects

Weill Cornell Medicine investigators have "reverse engineered" ketamine's antidepressant effects to identify potential new strategies for treating depression.

4 May 2026